InnoCare Pharma Limited (HKG:9969)

InnoCare Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	26,409	23,687	12,220	13,112	23,452	21,094
Market Cap Growth	41.86%	93.84%	-6.80%	-44.09%	11.18%	21.38%
Enterprise Value	20,326	17,849	6,114	4,689	14,292	15,136
Last Close Price	13.11	12.30	6.12	6.89	13.64	15.30
PE Ratio	36.94	33.13	-	-	-	-
PS Ratio	9.99	8.96	11.38	16.11	33.17	16.48
PB Ratio	3.06	2.75	1.70	1.66	2.71	3.04
P/TBV Ratio	3.08	2.77	1.78	1.73	2.75	3.09
P/OCF Ratio	-	-	-	-	-	102.87
EV/Sales Ratio	7.69	6.75	5.69	5.76	20.22	11.82
EV/EBITDA Ratio	23.50	20.63	-	-	-	-
EV/EBIT Ratio	25.72	22.58	-	-	-	-
Debt / Equity Ratio	0.20	0.20	0.23	0.23	0.20	0.23
Debt / EBITDA Ratio	2.01	2.01	-	-	-	-
Net Debt / Equity Ratio	-0.71	-0.71	-0.80	-0.92	-0.98	-0.87
Net Debt / EBITDA Ratio	-7.06	-7.06	11.36	10.84	10.21	29.54
Net Debt / FCF Ratio	-	-	12.23	7.21	9.42	1821.44
Asset Turnover	0.24	0.24	0.10	0.07	0.07	0.18
Inventory Turnover	1.48	1.48	1.29	1.39	3.81	11.13
Quick Ratio	5.41	5.41	7.01	4.13	4.43	19.29
Current Ratio	5.77	5.77	7.45	4.21	4.48	19.49
Return on Equity (ROE)	8.89%	8.89%	-6.50%	-8.71%	-13.44%	-1.51%
Return on Assets (ROA)	4.39%	4.39%	-3.52%	-4.15%	-5.48%	-1.91%
Return on Invested Capital (ROIC)	38.95%	38.98%	-58.29%	-186.05%	-174.16%	-33.69%
Return on Capital Employed (ROCE)	7.50%	7.50%	-6.50%	-8.60%	-9.40%	-2.60%
Earnings Yield	2.71%	3.02%	-3.84%	-5.30%	-4.27%	-0.38%
FCF Yield	-	-	-3.86%	-7.73%	-3.82%	-0.02%
Buyback Yield / Dilution	-	-	0.67%	-15.31%	-8.29%	-41.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.